Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population: A two-year experience in a nonuniversity setting

Neuroendocrine tumors (NETs) are rare, but the incidence and prevalence of NETs are increasing in the United States. While surgery is the preferred treatment for NETs, it is not a viable option for metastatic disease. Lutathera ((177)Lu-DOTATATE) is approved by the United States Food and Drug Admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejia, Alejandro, Vivian, Elaina, Nwogu, Christiana, Shah, Jimmy, Longoria, Raquel, Vo, Allison, Shahin, Islam, Verma, Jonathan, Bageac, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896579/
https://www.ncbi.nlm.nih.gov/pubmed/35244064
http://dx.doi.org/10.1097/MD.0000000000028970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896579/
https://www.ncbi.nlm.nih.gov/pubmed/35244064
http://dx.doi.org/10.1097/MD.0000000000028970

Ejemplares similares